Phase I
Discover how to take Time and Cost out of Clinical Trials in 11 minutes
May 11 by Niamh MadiganThe proportion of clinical trials in Phase I has increased significantly in the last number of years. This coupled with a number of Phase III failures has put increased emphasis on making the right...
Infographic: Phase I Clinical Trials European Update 2011
August 23 by Sumit DuttaEver wondered how many Phase I Clinical Trials are happening in Europe? This map gives a comprehensive overview of the phase I trials taking place in the EU. (click th...
Improving Biomarker Development Work Flow in Phase I Clinical Development
September 07 by Helen WinsorReto Ossola, Group Leader for Biomarker Research at Biognosys, joins Pharma IQ to discuss the main challenges in biomarker development and some key ways to address these. Ossola offers some best...
Streamlining the Development and Validation Process in Discovery to Phase I Clinical Development
September 05 by Pharma IQReto Ossola, Group Leader for Biomarket Research at Biognosys, joins Helen Winsor from Pharma IQ, to discuss phase I clinical development. He outlines where he sees the main challenges in biomarker de...
Fail Early in Clinical Development if You Want to Succeed
June 10 by Andrea CharlesIf you are going to fail, it is better to fail earlier. All phases of clinical research are striving to reduce attrition, streamline their processes and develop drugs cost-effectively.
Top Tips for Utilising Imaging Techniques in Early Phase Clinical Trials
March 29 by Jan PasschierJan Passchier, Director PET and Radiochemistry, GlaxoSmithKline, talks to Pharma IQ, about the latest developments in imaging techniques and uses, ahead of Pharma IQ's 2nd Annual Innovation...